Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

23.05
Delayed Data
As of Jul 26
 +0.20 / +0.88%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.32%
Year-to-Date
Today's Dead Cat Bounce Stock: Valeant Pharmaceuticals International (VRX)
Jul 25 / TheStreet.com - Paid Partner Content
Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles
Jul 20 / TheStreet.com - Paid Partner Content
3 Stocks That Have Been Cut in Half Over the Past Year
Jul 25 / MotleyFool.com - Paid Partner Content
Here's the Most Overrated Investing Metric You'll Ever See
Jul 20 / MotleyFool.com - Paid Partner Content
Valeant Hits Another Bump
Jul 22 / TheStreet.com - Paid Partner Content
Morning Movers: MS, VRX, MSFT, ISRG
Jul 20 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment
Jul 22 / TheStreet.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
Valeant Drug Approval Hampered by FDA Facility Inspection
Jul 22 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals' Second-Largest Shareholder Just Abandoned Ship -- Should You...
Jul 15 / MotleyFool.com - Paid Partner Content
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Ionis Pharmaceuticals, In...
Jul 15 / MotleyFool.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Why Cree, Harsco, and Valeant Pharmaceuticals Jumped Today
Jul 14 / MotleyFool.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Company News for July 14, 2016
Jul 14 / Zacks.com - Paid Partner Content
Valeant's Drug Approvals May Save the Day
Jul 20 / TheStreet.com - Paid Partner Content
Casella Waste, Valeant Pharma, Yum Brands and CSX highlighted as Zacks Bull and Bear ...
Jul 14 / Zacks.com - Paid Partner Content
Jim Cramer -- Valeant Needs These New Drug Approvals
Jul 20 / TheStreet.com - Paid Partner Content
Bear of the Day: Valeant Pharma (VRX)
Jul 14 / Zacks.com - Paid Partner Content
Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug
Jul 20 / TheStreet.com - Paid Partner Content
3 Prime Reasons Why Valeant Pharmaceuticals Intl. Inc. Plunged 29% in June
Jul 13 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content